#3 - Marriott International (NASDAQ:MAR)
The hotel sector was one of the hardest hit by the pandemic. And the stock chart of Marriott International (NASDAQ:MAR) shows the effect of pent-up demand. For the first two months of the year, MAR stock charged to a 52-week high. But since then the stock has lost over 10%. However with one of the largest footprints in the United States, Marriott looks like a strong buy-the-dip candidate.
The company helped itself with its latest earnings report. Adjusted earnings beat analysts’ expectations by four cents. And while revenue was a slight miss, the company posted a sequential gain and, more significantly management said that occupancy rates were increasing in correlation with the Covid-19 vaccine rollout.
In fact, Marriott says demand is rebounding rapidly in several key areas. That will be a key metric to watch as investors will be looking for solid beats of pandemic revenue numbers.
Like many companies, Marriott suspended its dividend early on in the pandemic. It has not given guidance for when the dividend may be reinstated.
About Marriott International
Marriott International, Inc engages in operating, franchising, and licensing hotel, residential, timeshare, and other lodging properties worldwide. It operates its properties under the JW Marriott, The Ritz-Carlton, The Luxury Collection, W Hotels, St. Regis, EDITION, Bvlgari, Marriott Hotels, Sheraton, Westin, Autograph Collection, Renaissance Hotels, Le Méridien, Delta Hotels by Marriott, Tribute Portfolio, Gaylord Hotels, Design Hotels, Marriott Executive Apartments, Apartments by Marriott Bonvoy, Courtyard by Marriott, Fairfield by Marriott, Residence Inn by Marriott, SpringHill Suites by Marriott, Four Points by Sheraton, TownePlace Suites by Marriott, Aloft Hotels, AC Hotels by Marriott, Moxy Hotels, Element Hotels, Protea Hotels by Marriott, City Express by Marriott, and St.
Read More - Current Price
- $284.29
- Consensus Rating
- Hold
- Ratings Breakdown
- 6 Buy Ratings, 13 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- $259.00 (8.9% Downside)
